Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» tocilizumab
tocilizumab
Genentech's tocilizumab shortage due to Covid-19 now hits CAR-T recipients, with FDA offering alternatives to help
Endpoints
Mon, 12/13/21 - 11:01 am
Genentech
tocilizumab
COVID-19
CAR-T
drug shortages
Arthritis drug cuts deaths in hospitalized Covid-19 patients, major study shows
Stat
Thu, 02/11/21 - 10:50 am
Roche
tocilizumab
COVID-19
clinical trials
New Indication for Roche’s Actemra Means First FDA Approved Drug to Treat Giant Cell Arteritis
RAPS.org
Mon, 05/22/17 - 12:47 pm
Roche
Actemra
FDA
giant cell arteritis
tocilizumab
Could an old Roche arthritis med become a pioneering PAH treatment?
BioPharma Dive
Thu, 01/7/16 - 09:32 am
Roche
PAH
pulmonary arterial hypertension
tocilizumab
Actemra
Tocilizumab Approval Causes Buzz
Elsevier Global Medical News
Tue, 01/12/10 - 09:59 am
tocilizumab
Roche
FDA
rheumatoid arthritis
Phase III Study Showed Two Years of ACTEMRA® (tocilizumab) Inhibited Progression of Joint Damage and Improved Disease Remission
Reuters
Sun, 10/18/09 - 10:58 am
Actemra
tocilizumab
rheumatoid arthritis
Genentech